|  | 
|  |  | 
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. | 
|   
 
    
    
    
Advanced Viral Research Corporation, OTC:BB, ADVR, with Corporate Headquarters in Yonkers, New York, is a new company, with it's flagship drug RETICULOSE, state of the art laboratory equipment, and  qualified first class research personnel. I have personally seen and toured this world-class laboratory, and I am very impressed with its furnishings and scientists at work. A renown Medical Doctor, Shalom Z. Hirschman, is the President and CEO and is doing an outstanding job moving the company forward. The old ADVR, with its past shenanigans, should be forgotten. The things that took place, before October 18, 1996(when Dr. Hirschman came on board), should be forgotten and forgiven. It is no more. The new company has made milestones in short order, compared to the old days. The new company is now moving forward. The company is now doing everything by the book. It is staying within the rules and regulations of the SEC and the FDA. ADVR has been steadily at work on satisfying the numerous FDA requests for more information about Reticulose, a potent anti-viral compound. I feel this company is on the move! It is time to get out of the old and fully into the new. Advanced Viral Research will not hype its stock, or let out rumors just to run the price of the stock up. ADVR is a full SEC reporting company. freeedgar.com Let us all give a big welcome and bring in THE NEW ADVR, put out the OLD ADVR to pasture and forgive and forget it. Let's do it together! FACT: The Barbados clinical trial shows no toxic side effects, of Reticulose and it shows considerable efficacy. I don't think any other drug can say that. asmusa.org FACT: The National Cancer Institute is moving right along in its study of Reticulose. biz.yahoo.com FACT: The Argentina situation is a very important development, for ADVR and Reticulose. There is more there than meets the eye! Did you realize that Argentina has modern world-class doctors? The days of the tainted overseas drug approvals are over. All countries have signed on with the World Health Organization (WHO) Guidelines, for the approval of all drugs. This is true, and even applies to Belarus. THE WHO GUIDELINES ARE VERY, VERY STRICT. They are just about as strict as our own FDA'S GUIDELINES. The one-move Argentina project should open the door to 350,000,000 people. This move could produce the first ever COMMERCIAL REVENUES for ADVR! biz.yahoo.com I believe that ADVR will, in time, become a renown, major research corporation. I think millions of lives can be saved by the drug Reticulose. I feel very positive about the future of Advanced Viral Research Corporation. | ||||||||||||||
| 
 
 | 
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings | 
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI | 
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |